A new study links glucosamine use to faster progression from MCI to dementia and identifies glycan metabolism as a potential new therapeutic target in Alzheimer’s disease.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/popular-joint-supplement-tied-faster-ad-progression-2026a1000k79?src=rss
Author :
Publish date : 2026-06-16 07:49:00
Copyright for syndicated content belongs to the linked Source.
